MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Fresenius Medical Care AG & Co KGaA

Open

25.66 3.93

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

24.68

Max

25.95

Belangrijke statistieken

By Trading Economics

Inkomsten

-146M

119M

Verkoop

325M

5.1B

K/W

Sectorgemiddelde

24.9

63.778

EPS

0.455

Dividendrendement

2.58

Winstmarge

2.338

Werknemers

111,513

EBITDA

-565M

281M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+10.95% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

2.58%

2.39%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

933M

15B

Vorige openingsprijs

21.73

Vorige sluitingsprijs

25.66

Technische score

By Trading Central

Vertrouwen

Neutral Evidence

Fresenius Medical Care AG & Co KGaA Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

21 mrt 2025, 08:19 UTC

Marktinformatie

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

25 feb 2025, 10:27 UTC

Marktinformatie
Winsten

Fresenius Medical Care's U.S. Volume Growth Is Unlikely to Reassure Investors -- Market Talk

15 jul 2024, 08:17 UTC

Marktinformatie

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

3 mei 2024, 08:20 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Fresenius' Disposal of Part of Its Rehabilitation Business Seems Positive -- Market Talk

Peer Vergelijking

Prijswijziging

Fresenius Medical Care AG & Co KGaA Prognose

Koersdoel

By TipRanks

10.95% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 27.45 USD  10.95%

Hoogste 28.9 USD

Laagste 26 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Fresenius Medical Care AG & Co KGaA - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

5 ratings

2

Buy

3

Hold

0

Sell

Technische score

By Trading Central

24.68 / 24.87Steun & Weerstand

Korte Termijn

Neutral Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

Weak Bullish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Fresenius Medical Care AG & Co KGaA

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.